Antiarrhythmic drugs for cardiac arrest with a shockable rhythm and their effect on outcomes: a systematic review with meta-analysis. [PDF]
EuropaceSchnaubelt S +9 more
europepmc +1 more source
Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system. [PDF]
Front Pharmacol, 2023 Wang F, Zhou B, Sun H, Wu X.
europepmc +1 more source
Catheter ablation vs antiarrhythmic drugs for persistent atrial fibrillation in hypertrophic cardiomyopathy. [PDF]
Heart Rhythm O2Shahrori Z +6 more
europepmc +1 more source
Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study. [PDF]
Br J Clin PharmacolMeinert FM +5 more
europepmc +1 more source
Blanking period antiarrhythmic drugs after catheter ablation for atrial fibrillation: a meta-analysis of randomized controlled trials. [PDF]
Front Cardiovasc Med, 2023 Chen G, Li G, Zhang D, Wang X, Guo X.
europepmc +1 more source
Effectiveness and safety of concomitant use of direct oral anticoagulants and antiarrhythmic drugs: a systematic review of observational studies. [PDF]
Eur J Clin PharmacolMeinert FM +3 more
europepmc +1 more source
Effects of Antiarrhythmic Drugs on Antiepileptic Drug Action-A Critical Review of Experimental Findings. [PDF]
Int J Mol Sci, 2022 Borowicz-Reutt KK.
europepmc +1 more source
Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic Drugs. [PDF]
Pharmaceuticals (Basel)Ellermann C +7 more
europepmc +1 more source
Omega-3 Fatty Acids as Antiarrhythmic Drugs: Upstream Target Modulators Affecting Acute and Long-Term Pathological Alterations in Cardiac Structure and Function. [PDF]
Crit Care Explor, 2023 Driscoll DF, Welty FK, Bistrian BR.
europepmc +1 more source
Addressing SARS-CoV-2 viroporins with antiarrhythmic drugs. [PDF]
EuropaceBloothooft M, Voigt N, de Boer TP.
europepmc +1 more source